Home - Products - Others - Other Targets - 2-(2-bromophenyl)-5-chloro-4H-3,1-benzoxazin-4-one

2-(2-bromophenyl)-5-chloro-4H-3,1-benzoxazin-4-one

CAS No. 1234707-32-4

2-(2-bromophenyl)-5-chloro-4H-3,1-benzoxazin-4-one( —— )

Catalog No. M22210 CAS No. 1234707-32-4

2-(2-bromophenyl)-5-chloro-4H-3,1-benzoxazin-4-one is an human neutrophil elastase inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 42 In Stock
5MG 34 In Stock
10MG 52 In Stock
25MG 87 In Stock
50MG 129 In Stock
100MG 193 In Stock
200MG 291 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    2-(2-bromophenyl)-5-chloro-4H-3,1-benzoxazin-4-one
  • Note
    Research use only, not for human use.
  • Brief Description
    2-(2-bromophenyl)-5-chloro-4H-3,1-benzoxazin-4-one is an human neutrophil elastase inhibitor.
  • Description
    2-(2-bromophenyl)-5-chloro-4H-3,1-benzoxazin-4-one is an human neutrophil elastase inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Neutrophil elastase (human)
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1234707-32-4
  • Formula Weight
    336.57
  • Molecular Formula
    C14H7BrClNO2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Clc1cccc2nc(oc(=O)c12)-c1ccccc1Br
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Vanillyl Alcohol

    Vanillyl alcohol is derived from vanillin. It is used to flavor food. It has been used in trials studying the treatment of Smoking.

  • LL-37, Human TFA (15...

    Human LL-37 is a 37 amino acid cationic (6+) peptide and has been widely studied. LL-37 penetrates the bacterial membrane and forms pores in the membrane.

  • Glutaminase-IN-1

    Glutaminase-IN-1 (CB839 derivative), a novel 1,3,4-selenodiazepine inhibitor of the renal-type glutaminase (KGA) variant, exhibited antitumor activity in an aggressive H22 hepatocellular carcinoma xenograft model.